Latest News About - Cytomegalovirus

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Friday, November 22, 2019

3:20:00 AM CET

Subscribe
RSS | MAP
Subscribe
subscribe | manage
Subscribe
current page | all pages
Subscribe
info | definition

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Most reported countries (24h)

Theme countries

AlertLevel (24h)

Alert level graph

 Previous 14 days average

Alert level:
 high   medium   low

Quotes... Extracted quotes

George Scangos said: “Vir Biotechnology was founded to leverage advances in immunology, creating new ways of combatting serious infectious diseases on a global scale,” External link

4-traders Tuesday, November 19, 2019 10:23:00 PM CET

Michael Keller says: "These preliminary results show that hexaviral-specific, virus-specific T-cells are safe and may be effective in preventing and treating multiple viral infections," External link

eurekalert Monday, November 18, 2019 6:55:00 PM CET

Prof Dr sagte: "Wir freuen uns sehr über das, was wir bislang erreicht haben und sind in der glücklichen Lage, aus dem ersten Programm, das wir entwickelt und lizenziert haben, einen signifikanten, kontinuierlichen Umsatzstrom generieren zu können. Dank der Einnahmen aus unserer Lizenzvereinbarung mit MSD für das bereits in den Markt eingeführte Letermovir können wir unsere eigene Pipeline, die auf die Entwicklung wirklich neuartiger Therapien gegen Infektionskrankheiten ausgerichtet ist, weiter ausbauen" External link

magyartokepiac Tuesday, November 12, 2019 9:22:00 AM CET

Megan Smith magyarázta: „A CMV-nek általában nincsenek külső tünetei, de együtt kell élnünk vele, mivel nincs rá gyógymód. Immunrendszerünk mindig serény a háttérben, amikor e vírussal van dolga” External link

hirkereso Friday, July 26, 2019 5:27:00 AM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.

Most active sources for this category

springerlink

prnewswire

pr-inside

onlinelibrary

slideshare

jvi

seatrade-global

finanznachrichten-en

newsmedical

4-traders